![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Author: Ververs F.F. Tessa
Publisher: Adis International
ISSN: 0312-5963
Source: Clinical Pharmacokinetics, Vol.48, Iss.10, 2009-10, pp. : 677-683
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Clinical Pharmacokinetics, Vol. 48, Iss. 1, 2009-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
By Segura Mireia Farré Magí Pichini Simona
Clinical Pharmacokinetics, Vol. 44, Iss. 6, 2005-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Paroxetine metabolism is affected by cytochrome P450 (CYP) 2D6 polymorphism
Inpharma, Vol. 1, Iss. 1468, 2004-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)